REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
13/10/2025
Voltar para busca
Dado oficial do USPTO
KINTOR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
14/10/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 35, 42, 44
Data de depósito
20/09/2018
Data de registro
13/10/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/10/2020
Última transação
14/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
99
Localização do titular
SUZHOU CITY, JIANGSU PROVINCE, CN
Examinador
LAPTER,ALAIN J
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word "KINTOR"; the letter "O" of the word "KINTOR" contains four white Chinese characters on a black background.
Titulares e representantes
Titulares
SUZHOU KINTOR PHARMACEUTICALS, INC.
Kintor Pharmaceutical Limited
Representantes
Alex Patel Patel IP, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicines for treatment of cancer; sachets for pharmaceutical purposesmedicines in the form of capsuleschemico-pharmaceutical preparationsdrugs for medical purposeschemical preparations for pharmaceutical purposesbiological preparations for medical purposeschemical preparations for medical purposesall of the foregoing for the treatment of cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; pharmaceutical products for the preventiondiagnosistreatment and adjunctive therapy of cancercardiovascular diseasenervous system diseasesinfectious diseasesrespiratory diseasesendocrine and metabolic diseasesmental disorderskin diseasediseases of the blood systemdigestive system diseasesimmune system diseasesdiseases of genitourinary systemocular diseasesotolaryngology and dentistry diseasesmusculoskeletal and connective tissue diseasesnutritional diseasesdiseases caused by external factorspoisoning and injury; compounds for treating cancer; pharmaceuticalsmedical and veterinary preparations for the preventiondiagnosistreatment and adjunctive therapy of cancercardiovascular diseasenervous system diseasesinfectious diseasesrespiratory diseasesendocrine and metabolic diseasesmental disorderskin diseasediseases of the blood systemdigestive system diseasesimmune system diseasesdiseases of genitourinary systemocular diseasesotolaryngology and dentistry diseasesmusculoskeletal and connective tissue diseasesnutritional diseasesdiseases caused by external factorspoisoning and injury; sanitary preparations for medical purposes; dietetic food and substancesdietetic foodssugar substitutesnutritional beveragesdietary supplements for weight loss adapted for medical and veterinary use; food for babies; dietary supplements for humans and animals; plasters and materialsgauze for medical dressings; materials for dental fillings and for sealing purposes; dental wax; disinfectants; preparations for destroying vermin; fungicides; herbicides
Classe 35
Retail pharmacy services; advertising services; business management; business administration services; providing office functions; informationadvisory and consultancy services relating to all the aforesaid services
Classe 42
Scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceutical products; biotechnology research; biochemistry and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; testing services for assessing the efficacy and safety of pharmaceuticals; preparation of reports relating to scientific research; analytical medical and scientific laboratory services; medical and scientific laboratory research and analysis; development of products; development of pharmaceutical preparations for the diagnosis and treatment of cancer; advisory services relating to scientific research; scientific and technological services in the field of pharmaceuticals and research and design relating theretoconsulting and advisory servicesCRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) services; industrial analysis and research services in the field of pharmaceuticals; design and development of computer hardware and software; informationadvisory and consultancy services relating to all the aforesaid services
Classe 44
Pharmaceutical compounding services; providing medical information and information relating to the diagnosticprophylactic and therapeutic properties of pharmaceuticals; medical advice in the field of medicinepharmacologymedical analysis and diagnostics; provision of medical services in the field of alternative medicine; providing medical information relating to medicinepharmacology and medical diagnosis; medicine and treatment prescription servicesservices relating to the diagnosis of illness and prescription of medicine; medicine and treatment prescription serviceshome health care servicesmanaged health care services; physical therapy services; medical diagnostic testingmonitoring and reporting services; medical services; veterinary services; hygienic and beauty salon and consultation services for human beings and animals; medicine and treatment prescription servicesinsecticide sprayingvermin extermination for agriculturehorticulture and forestry; informationadvisory and consultancy services relating to all the aforesaid services
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/05/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
23/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
23/04/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
23/04/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
13/10/2020
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
04/09/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/09/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
10/07/2020
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
10/07/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/07/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/07/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/07/2020
CHPB
POST PUBLICATION AMENDMENT - ENTERED
14/02/2020
APET
ASSIGNED TO PETITION STAFF
12/02/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
21/01/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
03/01/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/11/2019
PUBO
PUBLISHED FOR OPPOSITION
26/11/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/10/2019
ALIE
ASSIGNED TO LIE
14/10/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/10/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
13/07/2019
GNSL
LETTER OF SUSPENSION E-MAILED
13/07/2019
CNSL
SUSPENSION LETTER WRITTEN
13/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/07/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/07/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/07/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/01/2019
GNRT
NON-FINAL ACTION E-MAILED
07/01/2019
CNRT
NON-FINAL ACTION WRITTEN
07/01/2019
DOCK
ASSIGNED TO EXAMINER
02/01/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
28/09/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/09/2018
NWAP
NEW APPLICATION ENTERED
24/09/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace KINTOR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.